As shown in Fig. 1, 125 early-stage HCC patients and 125 healthy controls matched in age and gender (P > 0.05 for both) were recruited to evaluate the potential value of anti-GNAS autoantibody in the early detection of HCC by ELISA. This evidence concerns the gene GNAS and hepatocellular carcinoma.